This message was posted by a user wishing to remain anonymous
HI All and hope everyone in this community is doing okay and/or has the resources they need. On to my work question: Has anyone had experience since the Covid-19 situation emerged with submitting non emergency and/or emergency research INDs to FDA? If so can you share any differences you have noted? (timing to process, additional justification needed to get processed, etc). I appreciate hearing about your experience either as the cross referencing commercial sponsor or as the IND holder planning to administer the investigational product.